Notification of Major Interest in Shares

22/04/2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):

ReGen Therapeutics Plc

2. Reason for the notification:

An acquisition or disposal of voting rights

3. Full name of person(s) subject to the notification obligation (iii):

Andrew Clement Wilson

4. Full name of shareholder(s) (if difference from 3):

As Above

5. Date of the transaction and date on which the threshold is crossed or reached (v):

20th April 2009

6. Date on which issued notified:

21st April 2009

7. Threshold(s) that is/are crossed or reached:

11% to 10%

8. Notified details

A: Voting rights attached to shares

Class/type of share if possible using the ISIN Code
GB00B28XMY25

Situation Previous to the triggering transaction (vi) –
Number of Shares                  2,506,750
  Number of Voting Rights (viii)  2,506,750

Resulting situation after the triggering transaction (viii) –
Number of Shares                             2,536,750
Number of Voting Rights – Direct (x)   2,536,750
  Number of Voting Rights – Indirect (xi)  N/A
  % of voting rights – Direct                  10.781%
% of voting rights – Indirect                 N/A
B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of financial instrument                N/A

Expiration date (xiii)                           N/A

Exercise/Conversion Period/Date (xiv)   N/A

Number of voting rights that may be acquired if the
instrument is exercised/converted        N/A

% of voting rights                               N/A

Total (A+B)

Number of voting rights     2,536,750

% of voting rights             10.781%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Proxy Voting:

10. Name of the proxy holder:                                               N/A

11. Number of voting rights proxy holder will cease to hold:        N/A

12. Date on which proxy holder will cease to hold voting rights:  N/A

13. Additional information:                Brewin Dolphin Act As Broker

14. Contact name:                                         Stephen Cartwright

15. Contact telephone number:                              0845 213 4014
For further information:

For further information, please contact:

Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396